מדיטבין 200 מ"ג

Země: Izrael

Jazyk: hebrejština

Zdroj: Ministry of Health

Aktivní složka:

GEMCITABINE AS HYDROCHLORIDE 200 MG/VIAL

Dostupné s:

MEDISON PHARMA LTD

ATC kód:

L01BC05

Léková forma:

POWDER FOR SOLUTION FOR INFUSION

Podání:

I.V

Výrobce:

INTAS PHARMACEUTICALS LTD, INDIA

Terapeutické skupiny:

GEMCITABINE

Terapeutické indikace:

Palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-FU refractory pancreatic cancer. Gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. Breast cancer: Gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated. Ovarian cancer: Gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.

Datum autorizace:

2012-11-01